A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Suzanne Ackloo und 59 weiteren Autor:innen. Beteiligte Einrichtung: Structural Genomics Consortium, University of Toronto, 101 College St., Toronto, ON M5G 1L7, Canada. Hauptthemen laut MEDLINE: WD40 Repeats. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, Bayer.
Abstract (Originalsprache)
Target class-focused drug discovery has a strong track record in pharmaceutical research, yet public domain data indicate that many members of protein families remain unliganded. Here we present a systematic approach to scale up the discovery and characterization of small molecule ligands for the WD40 repeat (WDR) protein family. We developed a comprehensive suite of protocols for protein production, crystallography, and biophysical, biochemical, and cellular assays. A pilot hit-finding campaign using DNA-encoded chemical library selection followed by machine learning (DEL-ML) to predict ligands from virtual libraries yielded first-in-class, drug-like ligands for 7 of the 16 WDR domains screened, thus demonstrating the broader ligandability of WDRs. This study establishes a template for evaluation of protein family wide ligandability and provides an extensive resource of WDR protein biochemical and chemical tools, knowledge, and protocols to discover potential therapeutics for this highly disease-relevant, but underexplored target class.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Structural Genomics Consortium, University of Toronto, 101 College St., Toronto, ON M5G 1L7, Canada.
- Google, 1600 Amphitheatre Parkway, Mountain View, California 94043, United States.
- ZebiAI Inc., 100 Beaver St., Waltham, Massachusetts 02435, United States.
- X-Chem Inc., 100 Beaver St., Waltham, Massachusetts 02435, United States.
- Relay Therapeutics, 399 Binney St., Cambridge, Massachusetts 02139, United States.
- Princess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G 2M9, Canada.
ORCID-Profile: Suzanne Ackloo, Matthew A Clark, John W Cuozzo, Jeremy S Disch, Jianwen A Feng, Elisa Gibson, Stuart R Green, Steven Kearnes, Serah W Kimani, Raquel A C Machado, Patrick Riley, Michael D Sintchak, Belinda L Slakman, Wen Torng, Ryan T Walsh, Derek J Wilson
Förderung
- NIGMS NIH HHS
- NIH HHS
- Bayer
- Merck KGaA
- Bristol-Myers Squibb Canada
- Genentech
- Takeda Canada
- Pfizer
Zitieren
APA
Ackloo, S., Li, F., Szewczyk, M., Seitova, A., Loppnau, P., Zeng, H., Xu, J., Ahmad, S., Arnautova, Y. A., Baghaie, A. J., Beldar, S., Bolotokova, A., Centrella, P. A., Chau, I., Clark, M. A., Cuozzo, J. W., Dehghani-Tafti, S., Disch, J. S., Dong, A., …, & Wilson, D. J. (2025). A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02010
Vancouver
Ackloo S, Li F, Szewczyk M, Seitova A, Loppnau P, Zeng H, et al. A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02010
BibTeX
@article{Ackloo2025,
author = {Ackloo, Suzanne and Li, Fengling and Szewczyk, Magda and Seitova, Almagul and Loppnau, Peter and Zeng, Hong and Xu, Jin and Ahmad, Shabbir and Arnautova, Yelena A and Baghaie, A J and Beldar, Serap and Bolotokova, Albina and Centrella, Paolo A and Chau, Irene and Clark, Matthew A and Cuozzo, John W and Dehghani-Tafti, Saba and Disch, Jeremy S and Dong, Aiping and Dumas, Antoine and Feng, Jianwen A and Ghiabi, Pegah and Gibson, Elisa and Gilmer, Justin and Goldman, Brian and Green, Stuart R and Guié, Marie-Aude and Guilinger, John P and Harms, Nathan and Herasymenko, Oleksandra and Houliston, Scott and Hutchinson, Ashley and Kearnes, Steven and Keefe, Anthony D and Kimani, Serah W and Kramer, Trevor and Kutera, Maria and Kwak, Haejin A and Lento, Cristina and Li, Yanjun and Liu, Jenny and Loup, Joachim and Machado, Raquel A C and Mulhern, Christopher J and Perveen, Sumera and Righetto, Germanna L and Riley, Patrick and Shrestha, Suman and Sigel, Eric A and Silva, Madhushika and Sintchak, Michael D and Slakman, Belinda L and Taylor, Rhys D and Thompson, James and Torng, Wen and Underkoffler, Carl and von Rechenberg, Moritz and Walsh, Ryan T and Watson, Ian and Wilson, Derek J},
title = {A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02010}
}
EUVIMED